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Dear Sir, 
We read with much interest the article of Kwak, et al.1 The authors report nor-
mal reference values of urinary albumin excretion (expressed as an albumin/creati-
nine ratio) in a normal population of normal children/adolescents aged 1 month to 
19 years old. Detection, evaluation and treatment of microalbuminuria (MA) has 
recently become an extremely important health issue, and screening of MA is now 
included in several national and international recommendations/guidelines for hy-
pertension (HTN)2 and diabetes mellitus (DM)3 management. The efficacy of early 
detection of albuminuria/proteinuria is further substantiated by powerful and effec-
tive treatment with angiotensin-converting enzyme inhibitors or angiotensin recep-
tor blockers, which have been shown to delay progression towards end-stage renal 
disease4 and decrease cardiovascular morbidity/mortality.5 Providing pediatricians 
with much needed reference values for urine albumin excretion is therefore a laud-
able exercise. Epidemiologic studies concerning urinary albumin excretion in chil-
dren are scarce, and most of them are conducted in subjects with pre-existing DM, 
obesity, or chronic kidney disease.6-8 Very few epidemiological studies have been 
performed in normal children.9-12 However, before adopting these newly published 
reference values, we would like to make the following comments in regards to 
some aspects of the study, more specifically patient descriptions, results reporting 
and statistical analysis. 
Selection of healthy subjects for the elaboration of reference intervals for a giv-
en measure is known to be fraught with difficulties. Subjects with a disease (overt 
or subclinical) can be hidden in the studied population and modify the distribution 
of the values for the measure in question.13 Kwak, et al. enrolled children in a busy 
outpatient clinic of a University Hospital in Korea.1 Children were reported as 
“healthy”, and although the authors excluded subjects with overt proteinuria, DM, 
renal disease or acute infection (all conditions known to cause MA/proteinuria), 
the exact reason for their visit was not stated. MA is also known to be associated 
with HTN,14 obesity,15 and DM/metabolic syndrome,16 all conditions which were 
not specifically mentioned in the paper. The authors should have reported if chil-
dren presented HTN, obesity or metabolic syndrome, all factors that could impact 
the presence of MA. Low body mass index (BMI) should have also been reported, 
as a (very) low muscular mass could alter creatinine excretion,17 hence the reason 
for the use of the albumin/creatinine ratio, although creatinine excretion was found 
to be within normal limits in patients with Duchenne Muscular Dystrophy.18 
Pre-analytical procedures should be described in more detail, given the potential 
(albeit small) impact of freezing urine on its albumin concentration.19 It is not clear 
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how albuminuria (RIA? HPLC?) and creatinine (compen-
sated Jaffé technique? enzymatic method?) were measured 
with the Toshiba 200 FR Neo, and this should be specified 
in order to increase the reproducibility of the results in sub-
sequent studies. The authors use the Schwartz formula for 
estimation of the glomerular filtration rate. The newly re-
vised Schwartz formulas have recently been shown to be 
more accurate, and should now be used for children aged 
one year and above with a deemed normal renal function.20 
Reference values should be subjected to careful statistical 
treatment, including partitioning, inspection of the distribu-
tion, identification and elimination of outliers.21,22 The au-
thors use parametric statistical methods (mean and standard 
deviation) to define the reference intervals. This is in con-
trast with the current recommendations of the International 
Federation for Clinical Chemistry (IFCC) who recom-
mended the use of non-parametric methods,13 although both 
methods may produce similar estimates of the percentiles. 
In this study, no data on the (assumed) normal distribution 
of the results or outliers identification were provided. The 
log transformation of spot urine MA/creatinine ratios might 
indeed indicate a non-Gaussian distribution of the results. 
However, there was no mention of how outliers were eval-
uated and eventually eliminated. Deletion of outliers can 
improve the characteristics of data distribution. While no 
statistical evaluation of outliers has the ability to predict 
outliers in every situation, there are several methods that 
are recommended, such as the Dixon/Reed method, which 
has been used extensively.21,23 Partitioning for subgroups 
according to age in pediatric studies should be based on 
strong statistical methods as well.24,25 It is not clear how age 
partitioning was performed in this study. Whenever possi-
ble, sample size targets should be determined at the start of 
the study.26
In summary and once again, the authors provided us with 
one of the few studies to describe reference values for albu-
min excretion in a population of healthy children, and they 
should be congratulated for that. However, given the above-
mentioned limitations, further research is needed, with stud-
ies including a larger number of well-defined healthy partici-
pants (the IFCC guidelines for establishing reference 
intervals recommend 120 reference subjects per subgroup or 
partition,13) which will allow us to obtain reference intervals 
with more robust statistical methods (non-parametric meth-
ods often give narrower reference intervals than those calcu-
lated by parametric statistics).26,27 Reference intervals calcu-
lated from small samples should be applied cautiously.26,27
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Although there were 7 children with more than 97 percen-
tile of body mass index (BMI), we did not observe any sig-
nificant difference in microalbumin/creatinine ratio. 
Random morning urine samples were stored in a refriger-
ator without freezing and processed within one hour. Urine 
microalbumin and creatinine were examined by Toshiba 
200 FR Neo (Toshiba Medical System Co., Tokyo, Japan) 
using the Jaffe technique. Glomerular filtration rates were 
obtained using the Schwartz formula.2 Although the newly 
revised Schwartz formula, which was based on height, se-
rum creatinine, cystatin C, blood urea nitrogen, and gender, 
have recently been shown to be more accurate, we could 
not use this formula because serum cystatin C was not fully 
obtained.3,4 As you mentioned, the original Schwartz for-
mula could overestimate glomerular filtration rate (GFR), 
and further studies using the new equation are required.
In this study, we divided subjects into five groups based 
on their age: from one to 12 months (Group 1), 12 to 28 
months (Group 2), 29 to 48 months (Group 3), 4 to 6 years 
(Group 4), and 7 to 19 years (Group 5). The International 
Federation for Clinical Chemistry (IFCC) guidelines for es-
tablishing reference intervals recommend 120 reference 
subjects per subgroup or partition, if using the classical non 
parametric protocol.5 And IFCC recommended evaluation 
and elimination of outliers using ‘Dixon/Reed one-third 
rule’.6,7 However, it was difficult to collect 120 samples for 
each age group in this study, which was conducted at a sin-
gle university hospital. And as you know, studies performed 
in children are known to have significant biological vari-
ability because during the childhood years, rapid and signif-
icant changes occur during growth and development.8 It 
was difficult to choose a partitioning method for subgroups, 
despite the availability of a few statistical approaches such 
as the Harris-Boyd method.9 In our study, we considered 
physiological changes according to age, and observed sta-
tistically significant differences in value among subgroups. 
GFR increases gradually to mature values when linear 
growth is completed during adolescence. Rhodin, et al.10 re-
ported that GFR is predicted to be 90% that of adult GFR at 
1-year postnatal age, and demonstrate a consistent relation-
ship from early prematurity to adulthood. Yap, et al.11 divid-
ed subjects into 2 subgroups, from neonate to 2 years and 2 
to 4 years, and presented the data according to age. So we 
decided to subdivide the subjects, aged 1 month to 19 years 
old, into five groups considering these physiological factors. 
In conclusion, although this study was performed at a 
single center and has limitations, it presented data describ-
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This study was conducted on 352 healthy children (185 
males and 167 females) who visited the pediatric depart-
ment at Konkuk University Hospital between July 2007 
and March 2010. The patients with overt proteinuria, renal 
diseases, diabetes mellitus, and acute infectious diseases 
were excluded. Actually, most of the subjects were follow-
up visit patients who were discharged with acute illnesses 
such as acute gastroenteritis, acute pharyngitis or viral pneu-
monia. We checked that they had no fever and no hyperten-
sion.1 Children with metabolic disease or other conditions 
that could potentially impact the presence of microalbumin-
uria were excluded. In this study, we measured the subjects’ 
height, weight, blood pressure, and serum creatinine. The z-
scores of the heights and weights were obtained using the 
LMS method and compared to 2007 Korean growth charts.1 
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ing a reference range for microalbuminuria in healthy chil-
dren. Further multicenter studies including a larger number 
of population is needed to determine the reference values 
for spot urine microalbumin/creatinine ratios in normal 
children.
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